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Background: Mycobacterium tuberculosis (Mtb) infects approx-
imately one third of the world’s population, 10% of which develop
disease during lifetime. Beijing genotype strains are the most pre-
dominant strains in China. The aim of this study was to screen and
validate the possible HLA*0201 restricted speciﬁc T cell epitopes of
latent phase Mtb strains H37Rv and Beijing genotype.
Methods & Materials: MTB DNA microarray gene expression
analysis was performed to screen the Mtb genes which expressed
up-regulated under hypoxia. SYFPEITHI and NetCTLpan databases
were used to predict the HLA-A*0201 restricted cytotoxic T lym-
phocyte (CTL) epitopes on Mtb, followed by peptide/HLA-A*0201
afﬁnity and complex stability assays using the T2 cells. IFN-gamma-
producing T cells were detected by enzyme-linked immunospot
assay (ELISPOT) and a LDH release assay were performed to
detect peptide-speciﬁc CTL activity using PBMC derived from HLA-
A*0201-positive human donors latently infected with Mtb (LTBI).
Results: Using a whole genome microarray, we identiﬁed 130
genes of Mtb strain H37Rv and Beijing genotype whose expres-
sion was up-regulated under hypoxic conditions, 37 genes were
responsible for encoding membrane protein, cell wall proteins
or exported proteins. Of selected four proteins coded by up-
regulated genes, Six potential epitopes on Rv0350, Rv0351 and
Rv0440 were selected as candidate HLA-A*0201 restricted CTL epi-
topes by SYFPEITHI and NetCTLpan prediction. Four of these 6
study epitopes (Rv0440 p416-424, Rv0440 p362-370, Rv0351 p122-130
and Rv0350 p363-371) were showed high binding afﬁnity and
stabilization to HLA-A*0201 molecules by T2 binding stud-
ies. Synthesis of multi-epitope peptides Rv0351-A-T (containing
Rv0351 p122-130, APDRE and Trojan peptide) and Rv0350-A-T
(containing Rv0350 p363-371, APDRE and Trojan peptide) via ufrin-
sensitive linker VRKR. Cytotoxic activity showed that signiﬁcant
lysis of T2cellspulsedwithRv0351-A-TorRv0350-A-Twas induced
by peptide-speciﬁc T cells derived from HLA-A*0201-positive LTBI.
IFN- gamma was released by PBMC in vitro from HLA-A*0201-
positive LTBI when challenged with the peptides by an ELISPOT
assay.
Conclusion: Our data suggest that Rv0351p122-130 and
Rv0350p363-371 are HLA-A*0201-restricted CTL epitopes and
could be useful in the design of an Mtb vaccine for LTBI.
Acknowledgments: This investigation was funded by a grant
from Key Projects in the National Science & Technology Program
(2009ZX10004-305).
http://dx.doi.org/10.1016/j.ijid.2014.03.1054
Type: Poster Presentation
Final Abstract Number: 56.016
Session: Tuberculosis and Other Mycobacterial Infections
Date: Friday, April 4, 2014
Time: 12:45-14:15
Room: Ballroom
Early treatment outcomes of patients with
extensively drug resistant tuberculosis in South
Africa
S. Janssen1, C.N. Menezes2, K. Dheda3, R. Louw4,
X. Padanilam4, M.P. Grobusch5
1 Academic Medical Center Amsterdam, Amsterdam,
Netherlands
2 University of the Witwatersrand, Johannesburg,
South Africa
3 University of Cape Town, Cape Town, South Africa
4 Sizwe Hospital for Tropical Diseases, Johannesburg,
South Africa
5 Academic Medical Centre - University of
Amsterdam, Amsterdam, Netherlands
Background: Drug-resistant tuberculosis is a major public
health threat. High mortality rates have been reported for patients
with extensively drug-resistant tuberculosis (XDR TB), particularly
in the case of co-infectionwithHIV. Early South-African reports tal-
liedanear-100%mortality rate in theTugelaFerryoutbreak (Gandhi
et al. Lancet 2006); pooled data from various institutions from
South Africa including SizweHospital reported an overallmortality
rate for XDR-TB patients after initiation of therapy of 36% (Dheda
et al. Lancet 2010).
Methods & Materials: This is a retrospective sub-analysis
of case records of adult patients treated for XDR TB (culture
conﬁrmed), who were all admitted toSizweHospitalinJohannes-
burg,South Africa, between June 2004 and September 2008.
Endpoints used were mortality and sputum culture conversion
(deﬁned as at least two consecutive negative cultures).
Results: Thirty-three patients for which comprehensive infor-
mation was available from the case records were included in the
analysis. The majority of patients was male (18/33, 54.5%) with a
meanageof 39.6 years (95%CI 31.9-41.8).HIV infectionwaspresent
in22/33 (66.7%) individuals. Individualswere followed for amedian
time of 11.8 months (IQR 9.1 months). Five of these patients died
(5/33, 15.2%), after a median time of 6.3 months (95% CI 2.0-10.5
months); 4 of them were HIV positive (4/5, 80%). Sputum culture
conversionoccurred in10 individuals (10/33, 30.3%), after amedian
time of 12.2 months (95% CI 3.9-24.8 months).
Conclusion: In a specialized hospital setting, mortality rates for
XDR TB patients can be considerably reduced well below a 20%
mortality threshold.
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